Evotec, Merck KGaA Collaborate on Neurological Disease Target

23.11.2010 - Evotec has signed an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery...